Tricuspid TEER: Mastering the Technique-Patient Selection for Tricuspid TEER, Dr. Chad Kliger

Patient Selection for Tricuspid TEER, Dr. Chad Kliger

Video Transcription

Video Summary

The discussion focuses on tricuspid regurgitation (TR) management and patient selection for therapeutic interventions. Ideal candidates exhibit symptoms like exertional dyspnea, fatigue, and edema. Medical management involves addressing left-sided valve diseases first, with options like SGLT2 inhibitors and diuretics. Advanced interventions consider the severity of TR, leaflet anatomy, and imaging quality. The Triluminate study reveals limited impact of medical therapy alone, highlighting the need for device therapy. Successful TR treatment depends on understanding the TR mechanism, leaflet anatomy, and procedural planning, aiming to restore leaflet coaptation effectively.

Keywords

tricuspid regurgitation

therapeutic interventions

SGLT2 inhibitors

Triluminate study

leaflet coaptation